Averting a malaria disaster

As treatments loose their effectiveness, morbidity and mortality from malaria will inevitably continue to rise. The rationale for combining drugs with independent modes of action is examined.

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Lancet (British edition) Ročník 353; číslo 9168; s. 1965 - 1967
Hlavní autoři:	White, NJ, Nosten, F, Looareesuwan, S, Watkins, WM, Marsh, K, Snow, RW, Kokwaro, G, Ouma, J, Hien, TT, Molyneux, ME, Taylor, TE, Newbold, CI, Ruebush, TK, Danis, M, Greenwood, BM, Anderson, RM, Olliaro, P
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Elsevier Ltd 05.06.1999 Lancet Elsevier Limited
Témata:	Animals Antimalarials - economics Antimalarials - therapeutic use Artemisinins Biological and medical sciences Costs and Cost Analysis Drug Resistance Drug therapy Drug Therapy, Combination Drugs, Chinese Herbal - therapeutic use Human protozoal diseases Humans Infectious diseases Malaria Malaria, Falciparum - drug therapy Malaria, Falciparum - epidemiology Malaria, Falciparum - prevention & control Medical research Medical sciences Parasitic diseases Protozoal diseases Pyrimethamine - therapeutic use Sesquiterpenes - therapeutic use Sulfadoxine - therapeutic use Tropical medicine Vector-borne diseases Epidemic Human Antimalarial Protozoal disease Chemoprophylaxis Costs Malaria Toxicity Artemisinin Parasitosis Infection Prevention Resistance Treatment Parasiticid
ISSN:	0140-6736, 1474-547X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!